Causes of Leukopenia in Elderly Patients
The most common causes of leukopenia in elderly patients are medications (particularly chemotherapy and immunosuppressants), myelodysplastic syndromes (MDS), nutritional deficiencies (B12, folate), chronic infections, autoimmune disorders, and hematologic malignancies—with MDS being particularly important to consider given its median age of diagnosis at 77 years 1.
Primary Etiologic Categories
Hematologic Malignancies and Bone Marrow Disorders
Myelodysplastic syndromes represent the most critical diagnosis to exclude in elderly patients with leukopenia, as the incidence increases dramatically with age—from 4.5 per 100,000 in the general population to 55.4 per 100,000 in those ≥80 years 1. MDS presents with cytopenias including leukopenia, and the median age at diagnosis is 77 years 1.
Chronic lymphocytic leukemia (CLL) should also be considered, as it primarily affects elderly adults with a median age at diagnosis of 72 years, and approximately 70% of patients are diagnosed after age 65 2. Acute myeloid leukemia (AML) has a crude incidence of 5-8 per 100,000 per year in European adults and increases with age 3.
Medication-Induced Leukopenia
Drug-induced leukopenia is extremely common in elderly patients, particularly those receiving:
- Chemotherapy agents (causing predictable myelosuppression)
- Immunosuppressants (tacrolimus, mycophenolate, azathioprine)
- Antimicrobials
- Antithyroid medications
- Anticonvulsants
Allergic agranulocytosis from medications represents an acute, potentially life-threatening cause 4.
Nutritional Deficiencies
Megaloblastic anemia from B12 or folate deficiency can cause leukopenia through impaired cell production 5. While folate deficiency has decreased since grain fortification began in 1998 6, B12 deficiency remains common in elderly patients due to decreased absorption.
Autoimmune and Inflammatory Conditions
Autoimmune neutropenia can occur, particularly in systemic lupus erythematosus (SLE), where anti-neutrophil antibodies may cause severe, treatment-refractory leukopenia 7. Hypersplenic syndrome with sequestration of white blood cells is another mechanism 5.
Infectious Causes
Chronic infections can cause leukopenia through increased utilization and destruction of white blood cells 5. Specific infectious etiologies (viral infections, malaria in travelers) should be considered based on exposure history 4.
Diagnostic Approach
Initial Evaluation Priority
When leukopenia is <1,000/μL, this represents an acute life-threatening emergency requiring immediate evaluation 4. For less severe leukopenia, the evaluation should be systematic:
- Detailed medication history: Document all prescription medications, over-the-counter drugs, and supplements—this is the most reversible cause
- Travel and exposure history: Recent travel abroad, sick contacts, occupational exposures
- Symptom assessment: Fever, weight loss, night sweats, bleeding, recurrent infections
- Physical examination findings: Splenomegaly, lymphadenopathy, skin rash, signs of hemorrhage 4
Laboratory Workup
For MDS evaluation specifically (given its prevalence in elderly):
- Complete blood count with differential and reticulocyte count
- Peripheral blood smear examination (looking for dysplastic changes)
- Bone marrow aspiration with iron stain and biopsy
- Cytogenetics
- Serum erythropoietin level (prior to RBC transfusion)
- RBC folate and serum B12
- Serum ferritin, iron, and total iron-binding capacity 8
For hematologic malignancy evaluation:
- Flow cytometry of peripheral blood (for CLL: requires demonstration of clonal B-cell population) 9
- Bone marrow examination when indicated based on peripheral findings
When to Perform Bone Marrow Biopsy
Bone marrow biopsy is indicated when:
- Unexplained persistent leukopenia after excluding reversible causes
- Concern for MDS based on dysplastic changes on peripheral smear
- Multiple cytopenias present
- Suspicion for hematologic malignancy based on flow cytometry or clinical presentation
Real-world data demonstrates that benign reversible causes are most prevalent, and flow cytometry is useful only in specific settings where lymphoproliferative disorder is suspected 10.
Clinical Pitfalls
The most common error is attributing leukopenia solely to age without thorough evaluation. While elderly patients may have slightly lower baseline white blood cell counts, persistent leukopenia warrants investigation given the high incidence of MDS and other serious conditions in this age group 1.
Another critical pitfall is failing to recognize medication-induced leukopenia early—a detailed medication reconciliation should be the first step, as this represents the most readily reversible cause 10, 5.
In elderly patients with comorbidities receiving multiple medications, leukopenia often has multifactorial origins, but each potential cause must be systematically evaluated rather than assumed 11.